HIV life cycle, innate immunity and autophagy in the central nervous system

Current Opinion in HIV and AIDS

Volumn 9, Issue 6, 2014, Pages 565-571

  Meulendyke, Kelly A ^a   Croteau, Joshua D ^a   Zink, M Christine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Central nervous system; HIV; Innate immunity

Indexed keywords

RAPAMYCIN; VITAMIN D;

ASTROCYTE; AUTOPHAGY; CENTRAL NERVOUS SYSTEM; HIV ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; LIFE CYCLE; MACROPHAGE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS ENTRY; VIRUS LATENCY; VIRUS REPLICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

AUTOPHAGY; CENTRAL NERVOUS SYSTEM; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; VIRUS REPLICATION;

EID: 84927617771     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000106     Document Type: Review

References (69)

1. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42:1736-1739.
2. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007; 27:86-92.
3. Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-2096.
4. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014; 69:833-842.
5. Churchill M, Nath A. Where does HIV hide? A focus on the central nervous system. Curr Opin HIV AIDS 2013; 8:165-169.
6. Arrildt KT, Joseph SB, Swanstrom R. The HIV-1 env protein: a coat of many colors. Curr HIV/AIDS Rep 2012; 9:52-63.
7. Johnston SH, Lobritz MA, Nguyen S, et al. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J Virol 2009; 83:11016-11026.
8. Joseph SB, Arrildt KT, Swanstrom AE, et al. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities. J Virol 2014; 88:1858-1869.
9. Salimi H, Roche M, Webb N, et al. Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5. J Leuk Biol 2013; 93:113-126.
10. Lane BR, Lore K, Bock PJ, et al. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 2001; 75:8195-81202.
11. Zheng JC, Huang Y, Tang K, et al. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J Neuroimmunol 2008; 200:100-110.
12. Mamik MK, Ghorpade A. Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-kappaB pathway. PLoS One 2014; 9:e92145.
13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
14. Owler L, Saksena NK. Micro-RNA: new players in HIV-pathogenesis, diagnosis, prognosis and antiviral therapy. AIDS Rev 2013; 15:3-14.
15. Harwig A, Das AT, Berkhout B. Retroviral microRNAs. Curr opin Virol 2014; 7C:47-54.
16. Swaminathan G, Navas-Martin S, Martin-Garcia J. MicroRNAs and HIV-1 infection: antiviral activities and beyond. J Mol Biol 2014; 426:1178-1197.
17. Swaminathan S, Murray DD, Kelleher AD. miRNAs and HIV: unforeseen determinants of host-pathogen interaction. Immunol Rev 2013; 254:265-280.
18. Sisk JM, Witwer KW, Tarwater PM, Clements JE. SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology 2013; 10:95.
19. Rebane A, Akdis CA. MicroRNAs: essential players in the regulation of inflammation. J Allergy Clin Immunol 2013; 132:15-26.
20. Sedger LM. microRNA control of interferons and interferon induced antiviral activity. Mol Immunol 2013; 56:781-793.
21. Ma L, Shen CJ, Cohen EA, et al. miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP. PLoS One 2014; 9:e99535.
22. Casey Klockow L, Sharifi HJ, Wen X, et al. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection. Virology 2013; 444:191-202.
23. Kumar A, Abbas W, Herbein G. HIV-1 latency in monocytes/macrophages. Viruses 2014; 6:1837-1860.
24. Marban C, Suzanne S, Dequiedt F, et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 2007; 26:412-423.
25. Cherrier T, Le Douce V, Eilebrecht S, et al. CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci U S A 2013; 110:12655-12660.
26. Eilebrecht S, Le Douce V, Riclet R, et al. HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters. Nucleic Acids Res 2014; 42:4962-4971.
27. Gray LR, Turville SG, Hitchen TL, et al. HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles (vol 9, e90620, 2014). PLoS One 2014; 9:e90620.
28. Narasipura SD, Kim S, Al-Harthi L. Epigenetic regulation of HIV-1 latency in astrocytes. J Virol 2014; 88:3031-3038.
29. Sgarbanti M, Battistini A. Therapeutics for HIV-1 reactivation from latency. Curr Opin Virol 2013; 3:394-401.
30. Shan L, Siliciano RF. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication. BioEssays 2013; 35:544-552.
31. Monroe K, Yang Z, Johnson J, et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2013; 343:428432.
32. Doitsh G, Galloway N, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505:509-514.
33. Zaritsky LA, Dery A, Leong WY, et al. Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung. J Interferon Cytokine Res 2013; 33:24-33.
34. Polyak MJ, Vivithanaporn P, Maingat FG, et al. Differential type 1 interferonregulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence. FASEB J 2013; 27:2829-2844.
35. Mogensen TH, Melchjorsen J, Larsen CS, Paludan SR. Innate immune recognition and activation during HIV infection. Retrovirology 2010; 7:54.
36. Tarassishin L, Bauman A, Suh HS, Lee SC. Antiviral and anti-inflammatory mechanisms of the innate immune transcription factor interferon regulatory factor 3: relevance to human CNS diseases. J Neuroimmune Pharmacol 2013; 8:132-144.
37. Yao H, Bethel-Brown C, Li CZ, Buch SJ. HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol 2010; 5:489-495.
38. Li J, Wang Y, Wang X, et al. Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages. Blood 2013; 121:2934-2942.
39. Geffin R, McCarthy M. Innate immune responses to HIV infection in the central nervous system. Immunol Res 2014; 57:292-302.
40. Dube M, Roy BB, Guiot-Guillain P, et al. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog 2010; 6:e1000856.
41. Tarassishin L, Bauman A, Suh HS, Lee SC. Antiviral and anti-inflammatory mechanisms of the innate immune transcription factor interferon regulatory factor 3: relevance to human CNS diseases. J Neuroimmune Pharmacol 2013; 8:132-144.
42. Hornik TC, Neniskyte U, Brown GC. Inflammation induces multinucleation of Microglia via PKC inhibition of cytokinesis, generating highly phagocytic multinucleated giant cells. J Neurochem 2014; 128:650-661.
43. Li J, Wang Y, Wang X, et al. Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages. Blood 2013; 121:2934-2942.
44. Geffin R, Martinez R, Perez R, et al. Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1. J Neuroimmune Pharmacol 2013; 8:1010-1026.
45. Cuervo AM. Autophagy: many paths to the same end. Mol Cell Biochem 2004; 263:55-72.
46. Fields J, Dumaop W, Rockenstein E, et al. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. J Neurovirol 2013; 19:89-101.
47. Zhou D, Masliah E, Spector SA. Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. J Infect Dis 2011; 203:1647-1657.
48. Spector SA, Zhou D. Autophagy: an overlooked mechanism of HIV-1 pathogenesis and neuroAIDS? Autophagy 2008; 4:704-706.
49. Campbell GR, Spector SA. Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011; 286:18890-18902.
50. Campbell GR, Spector SA. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Path 2012; 8:e1003017.
51. Campbell GR, Spector SA. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathogens 2012; 8:e1002689.
52. Espert L, Varbanov M, Robert-Hebmann V, et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009; 4:e5787.
53. Deneka M, Pelchen-Matthews A, Byland R, et al. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 2007; 177:329-341.
54. Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 2003; 162:443-455.
55. Kyei GB, Dinkins C, Davis AS, et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 2009; 186:255-268.
56. Gregoire IP, Richetta C, Meyniel-Schicklin L, et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathogens 2011; 7:e1002422.
57. Campbell GR, Spector SA. Inhibition of human immunodeficiency virus type-1 through autophagy. Curr Opin Microbiol 2013; 16:349-354.
58. Nardacci R, Amendola A, Ciccosanti F, et al. Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients. Autophagy 2014; 10.
59. Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64:113-222.
60. Pickford F, Masliah E, Britschgi M, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 2008; 118:2190-2199.
61. Crews L, Spencer B, Desplats P, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 2010; 5:e9313.
62. Cuervo AM, Stefanis L, Fredenburg R, et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004; 305: 1292-1295.
63. Scott JC, Woods SP, Carey CL, et al. Neurocognitive consequences of HIV infection in older adults: an evaluation of the 'cortical' hypothesis. AIDS Behav 2011; 15:1187-1196.
64. Lake JE, Adams JS. Vitamin D in HIV-infected patients. Curr HIV/AIDS Rep 2011; 8:133-141.
65. Nicoletti F, Lapenta C, Donati S, et al. Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin. Clin Exp Immunol 2009; 155:28-34.
66. Viard JP, Souberbielle JC, Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011; 25:1305-1315.
67. Campbell GR, Spector SA. Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy 2012; 8:1523-1555.
68. Delgado MA, Elmaoued RA, Davis AS, et al. Toll-like receptors control autophagy. EMBO J 2008; 27:1110-1121.
69. Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 2013; 494:201-206.